SG Americas Securities’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.08M | Buy |
|
|||||
|
2025
Q2 | $351K | Sell |
|
|||||
|
2025
Q1 | $716K | Buy |
|
|||||
|
2024
Q4 | $172K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $558K | Sell |
|
|||||
|
2024
Q1 | $809K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $880K | Buy |
|
|||||
|
2023
Q2 | $611K | Sell |
|
|||||
|
2023
Q1 | $1.75M | Sell |
|
|||||
|
2022
Q4 | $2.53M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $716K | Buy |
|
|||||
|
2022
Q1 | $641K | Sell |
|
|||||
|
2021
Q4 | $1.31M | Buy |
|
|||||
|
2021
Q3 | $349K | Sell |
|
|||||
|
2021
Q2 | $881K | Buy |
|
|||||
|
2021
Q1 | $738K | Sell |
|
|||||
|
2020
Q4 | $1.28M | Buy |
|
|||||
|
2020
Q3 | $780K | Sell |
|
|||||
|
2020
Q2 | $1.25M | Buy |
|
|||||
|
2020
Q1 | $483K | Sell |
|
|||||
|
2019
Q4 | $1.13M | Buy |
|
|||||
|
2019
Q3 | $144K | Sell |
|
|||||
|
2019
Q2 | $343K | Sell |
|
|||||
|
2019
Q1 | $790K | Sell |
|
|||||
|
2018
Q4 | $1.99M | Buy |
|
|||||
|
2018
Q3 | $1.3M | Sell |
|
|||||
|
2018
Q2 | $2.14M | Buy |
|
|||||
|
2018
Q1 | $218K | Buy |
|
|||||
|
2017
Q4 | $145K | Sell |
|
|||||
|
2017
Q3 | $600K | Buy |
|
|||||
|
2017
Q2 | $274K | Sell |
|
|||||
|
2017
Q1 | $353K | Sell |
|
|||||
|
2016
Q4 | $943K | Buy |
|
|||||
|
2016
Q3 | $258K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $140K | Sell |
|
|||||
|
2015
Q4 | $169K | Sell |
|
|||||
|
2015
Q3 | $239K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $358K | Sell |
|
|||||
|
2014
Q4 | $358K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $257K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $130K | Sell |
|
|||||
|
2013
Q2 | $152K | Buy |
|